- Research
- Open Access

# MR thermometry characterization of a hyperthermia ultrasound array designed using the *k*-space computational method

- Osama M Al-Bataineh
^{1}, - Christopher M Collins
^{2}, - Eun-Joo Park
^{1}, - Hotaik Lee
^{3}and - Nadine Barrie Smith
^{3}Email author

**5**:56

https://doi.org/10.1186/1475-925X-5-56

© Al-Bataineh et al; licensee BioMed Central Ltd. 2006

**Received: **13 December 2005

**Accepted: **25 October 2006

**Published: **25 October 2006

## Abstract

### Background

Ultrasound induced hyperthermia is a useful adjuvant to radiation therapy in the treatment of prostate cancer. A uniform thermal dose (43°C for 30 minutes) is required within the targeted cancerous volume for effective therapy. This requires specific ultrasound phased array design and appropriate thermometry method. Inhomogeneous, acoustical, three-dimensional (3D) prostate models and economical computational methods provide necessary tools to predict the appropriate shape of hyperthermia phased arrays for better focusing. This research utilizes the *k*-space computational method and a 3D human prostate model to design an intracavitary ultrasound probe for hyperthermia treatment of prostate cancer. Evaluation of the probe includes *ex vivo* and *in vivo* controlled hyperthermia experiments using the noninvasive magnetic resonance imaging (MRI) thermometry.

### Methods

A 3D acoustical prostate model was created using photographic data from the Visible Human Project^{®}. The *k*-space computational method was used on this coarse grid and inhomogeneous tissue model to simulate the steady state pressure wavefield of the designed phased array using the linear acoustic wave equation. To ensure the uniformity and spread of the pressure in the length of the array, and the focusing capability in the width of the array, the equally-sized elements of the 4 × 20 elements phased array were 1 × 14 mm. A probe was constructed according to the design in simulation using lead zerconate titanate (PZT-8) ceramic and a Delrin^{®} plastic housing. Noninvasive MRI thermometry and a switching feedback controller were used to accomplish *ex vivo* and *in vivo* hyperthermia evaluations of the probe.

### Results

Both exposimetry and *k*-space simulation results demonstrated acceptable agreement within 9%. With a desired temperature plateau of 43.0°C, *ex vivo* and *in vivo* controlled hyperthermia experiments showed that the MRI temperature at the steady state was 42.9 ± 0.38°C and 43.1 ± 0.80°C, respectively, for 20 minutes of heating.

### Conclusion

Unlike conventional computational methods, the *k*-space method provides a powerful tool to predict pressure wavefield in large scale, 3D, inhomogeneous and coarse grid tissue models. Noninvasive MRI thermometry supports the efficacy of this probe and the feedback controller in an *in vivo* hyperthermia treatment of canine prostate.

## Keywords

## Background

Prostate cancer causes approximately 30,000 deaths among Americans every year with more than 230,000 new patients in 2004 [1]. Most of the patients are elderly and often can not withstand invasive surgical procedures to eradicate the tumor in its early stages [2]. Radiation and hormone therapies are still the treatment of choice for these patients [3]. Thermal treatment has shown to be effective in therapy for different kinds of tumors including prostate cancer [4–8]. Hyperthermia therapy raises the temperature of the tumor and a surrounding margin of normal tissue from the normal body temperature of 37°C to 42–45°C [9–11]. This type of treatment has had success, in either as simultaneous or sequential adjunct to radiation therapy, in enhancing the cytotoxic effect of the radiation therapy [12–15]. Noninvasive ultrasound intracavitary hyperthermia technology is an accepted thermal treatment for prostate cancer [16].

Many previous simulation and design studies of intracavitary ultrasound phased have considered multiple layered media but not necessarily a three-dimensional anatomical prostate model [17–23]. Previous intracavitary ultrasound hyperthermia phased arrays used small cylindrical radiators to conform to the natural contours of large body orifices [24, 25]. Simulations of previous hyperthermia and high intensity focused ultrasound (HIFU) phased arrays were accomplished using the Rayleigh-Sommerfeld integral over a set of geometrically superimposed point sources [26]. Homogeneous water-like media were used to simulate pressure field distributions of these arrays [17–20, 24, 25]. Such simulations, however, do not capture the interaction of ultrasound with inhomogeneous tissue structures. Modeling of ultrasound wave propagation in inhomogeneous three-dimensional (3D) structure or medium over large length scales has become feasible using the *k*-space computational method [27–31]. This method solves the spatial terms of the wave equation by Fourier transformation to the spatial frequency domain, while temporal iterations are performed using a nonstandard finite difference approach using the *k*-t space propagator (where *k* represents the spatial frequency domain and t represents the time domain) [27]. It provides computational improvements over pseudospectral methods, in which the spatial derivatives are evaluated globally by Fourier transformation and wavefields are advanced in time using second order accurate finite differences (leapfrog propagator) [32]. The *k*-space method maintains its accuracy up to a Courant-Friedrichs-Lewy number (CFL = c_{0}Δt/Δx, where c_{0} is the sound speed; Δt is the temporal step; Δx is the spatial step) of about 0.4 [27]. However, the pseudospectral method [27] rapidly increases in error for CFL numbers above 0.1. For weak scattering media, the *k*-space method provides similar value for time steps two to three times larger than those required by high order pseudospectral methods [27]. Compared to finite difference computations [33], in which both spatial and temporal second order partial derivatives are solved using second order finite difference computations, the *k*-space method produces practical results for much larger spatial step size. Equivalent accuracy is achieved employing only three points per minimum wavelength using the *k*-space method compared to 14 points per minimum wavelength for the finite difference equation using the same criterion. For 3D calculations, this reduction in the spatial size reduces the storage requirements for the *k*-space computations compared to finite difference method by 98% [27].

Noninvasive magnetic resonance imaging (MRI) thermometry is helpful in monitoring and controlling hyperthermia treatment of the prostate gland [21, 34–36]. It is important in this therapy to keep the temperature of the healthy tissue below the targeted temperature of the cancerous volume. A feedback control system is useful in maintaining the targeted tissue within the required thermal dose for cytotoxicity (43°C for 30 minutes) [37]. This research focuses on acoustical modeling of a 4 × 20 element hyperthermia phased array, exposimetry testing, and *ex vivo* and *in vivo* evaluation of the probe utilizing MRI thermometry.

## Methods

### Phased array design and the k-space acoustic modelling

^{®}library (U.S. National Library of Medicine, Bethesda, MD). Figure 2 shows a transverse (yz-plane) photographic slice of this model. It has 64 × 64 mm dimensions with a 0.25 mm grid size. The prostate gland, the rectal wall, the skeletal muscle, the fat tissue, and the added water-like medium in the rectum are marked and labeled in the figure. The optical parameters that define the fractional fat, connective, glandular and muscle soft tissues of each pixel were used to build a three-dimensional acoustical model. The 3D photographic data permitted development of three sets of 3D acoustical data: sound speed, density and absorption parameters[27, 38]. More details of the mapping procedure are presented elsewhere [39]. The prostate model was used to simulate the pressure distribution of the hyperthermia phased array by means of the

*k*-space computational method.

The *k*-space method was used to study pressure beam formation of the designed phased array through the prostate model. The linear acoustic wave equation was used for the simulation:

$\nabla \cdot (\frac{1}{\rho (x,y,z)}\nabla p(x,y,z,t))-\frac{1}{\rho (x,y,z){c}^{2}(x,y,z)}\frac{{\partial}^{2}p(x,y,z,t)}{\partial {t}^{2}}=\frac{\alpha (x,y,z)}{\rho (x,y,z){c}^{2}(x,y,z)}\frac{\partial p(x,y,z)}{\partial t}$

where, ∇·( ) is the spatial divergence operator; ∇( ) is the spatial gradient operator; *ρ*(*x*, *y*, *z*) is the spatially dependent density (kg/m^{3}); *c*(*x*, *y*, *z*) is the spatially dependent sound speed (m/s); *p*(*x*, *y*, *z*, *t*) is the spatially and temporally dependent pressure (Pa); *α*(*x*, *y*, *z*) is the spatially dependent absorption coefficient (s^{-1}, the absorption in dB/m equals to 20 × log_{10}(e) × *α*(*x*, *y*, *z*)/(2c_{0}) [39]). All absorption effects (viscous, heat conduction and internal molecular processes losses) were represented by a single absorption coefficient which was equivalent to the inverse of a spatially dependent relaxation time [40]. The *k*-t propagator was used to solve for the propagation in the inhomogeneous prostate model after setting both initial and boundary conditions [27]. The dimensions of the model were 64 × 64 × 46 mm with 0.25 mm spatial step size. It was composed of 257 × 257 × 185 discrete points. The temporal step size was 0.082 μs. A tapered absorption boundary layer, all around the model, was created to prevent wave wrapping from side to side and to prevent reflection of the waves at the boundaries. This layer is mathematically described elsewhere [39]. A single segment of the phased array was incorporated in the acoustical model for simulation purposes. Virtual elements with 1 × 14 mm dimensions were integrated in the simulation. The established grid size of 0.25 mm for the model limited the effective kerf width (dice thickness) of the array to this number. Each sub-element added to the overall virtual source that induced pressure to the surrounding media, depending on the acoustical parameters of each point of the model. All points that related to a specific element were driven temporally in a sinusoidal fashion with a 1.2 MHz resonance frequency and a particular phase shift that compensated for its path length to a specific target. Greater details regarding the simulations with respect to the design of the array are described elsewhere [29–31].

*k*-space simulated normalized pressure squared distribution and the absorption variations of the previously shown slice in Figure 2. The dimensions of the slice are 64 × 64 mm. The white colored boundaries of the image represent the tapered absorption layer, which prevents the reflection and wrapping of the ultrasound waves at the boundaries. The phased array is located 5 mm away from the absorbing boundary layer. It is coupled to the rectal wall through the water medium. The pressure squared distribution is represented by the white colored waves on top of the absorption gray-scale distribution. Inhomogeneous tissue composition through the rectal wall and the prostate gland causes irregularity of the focused beam. The acoustic energy is focused inside the prostate gland 40 mm away from the phased array.

### Hyperthermia phased array exposimetry testing

The hyperthermia phased array system was tested using an in-house automated exposimetry system based on the American Institute of Ultrasound in Medicine and National Electrical Manufacturers Association (AIUM/NEMA) guidelines [41]. The array was submerged in an anechoic tank (122 × 51 × 53 cm) filled with degassed distilled water. A needle-type hydrophone (precision Acoustics Ltd., Dorchest, UK) was placed perpendicular to the face of the transducer to measure pressure field values at discrete points. While focusing the acoustical energy 40 mm axially away from the face of the transducer, seven scans were acquired in the propagation direction for a single segment of the phased array. The average values of these scans were compared to *k*-space and Rayleigh-Sommerfeld simulation results.

Unlike *k*-space computations, the Rayleigh-Sommerfeld simulations computed the pressure distribution produced by a single segment of the phased array by summing the pressure contributions of individual simple sources along the extracted lines. The kerf width was 0.12 mm and the simulations were performed in water medium without the inclusion of the absorption term.

*k*-space in water medium, and

*k*-space in prostate model simulations. The

*k*-space simulation in the prostate model shows that the inhomogeneous tissue structure of the rectal wall and the prostate gland cause focusing aberration and elevation of the pressure values (< -3 dB) within the nearfield region compared to exposimetry and other simulations. Rapid decrease in the pressure values of the

*k*-space prostate simulation is due to the relatively high absorption values of this extracted axial line which mostly composed of connective tissue with absorption values of 110 dB/m. Both exposimetry results and

*k*-space water simulation results show acceptable agreement within a 9% calculated error when comparing the -3 dB widths of the focal volume. Rayleigh-Sommerfeld simulation shows deviation of the results compared to the

*k*-space simulations and exposimetry results. This deviation is due to performing the calculations of the pressure values without the inclusion of absorption effects.

### MRI thermometry methods

*Ex vivo*and

*in vivo*hyperthermia evaluations of the probe were made using MRI thermometry and a switching feedback controller. Figure 5 shows the setup for the hyperthermia experiments. A personal computer used as a switching temperature controller was connected via an RS232 serial port to the digital power amplifier (UDS 2050PA, Advanced Surgical Systems, Inc. Tucson, AZ) and to the console of the magnetic resonance imaging system (3 Tesla MEDSPEC S300, Bruker BioSpin, Ettlingen, Germany). The ultrasound transrectal probe was coupled to either

*ex vivo*bovine tissue samples (phantom) or

*in vivo*canine prostate gland using an inflated bolus of circulated water. The transducer was connected to the driving power amplifier. Water hoses were connected to a water pump (Cole-Parmer Instrument Company, Barrington, IL) via a bubble trap chamber and air hoses were connected to an air pump. Depending on feedback temperature values, the switching controller adjusted the driving power of each ultrasound channel by signaling the power amplifier system on and off. Temperature values were calculated from the phase shift of the acquired MRI images as follows [42]:

ΔT = Δφ/(α γ TE B_{0})

where, ΔT is the relative temperature (°C); Δφ is the phase difference (rad); α is the temperature dependent chemical shift (-0.00909 ppm/°C); γ is the gyromagnetic ratio (rad/s.T); TE is the echo time (s), and B_{0} is the magnetic field (T). A spoiled gradient (SPGR) echo sequence was used to acquire thermal images for the feedback controller. More details are presented elsewhere [36].

For *ex vivo* experiments, the transrectal probe and its bolus were held close to the bovine tissue sample and the whole apparatus was inserted in the RF head coil and was placed in the uniform static magnetic field and gradient coils. A base line image was produced using these parameters: repetition time TR = 100 ms, echo time TE = 15 ms, flip angle = 30°, data matrix = 64 × 64, field of view (FOV) = 12 × 12 cm, and slice thickness = 4 mm. The ultrasound transducer was excited for 5 minutes before acquiring another image. Phase difference values, between base image (before driving the transducer) and an image after five minutes of driving the transducer, were used to calculate temperature variations in the selected slice. The MRI-derived average temperature of a 2 × 3 pixel region was used as an input to the controller. *In vivo* animal experiments were conducted with procedures approved by the Penn State Institutional Animal Care and Use Committee (IACUC). A mongrel-type canine (3 years old, 10 kg) was anesthetized with Telazol (100 mg/ml, reconstituted with Tiletamine hydrochloric acid and Zolazepam hydrochloric acid, Fort Dodge Animal Health, Fort Dodge, IA) and was placed inside the magnet. The rectum of the dog was manually cleaned and was filled with ultrasound gel using a syringe. The transrectal probe was inserted in the rectum facing the prostate gland. The vital readings of the animal were periodically checked and recorded. MRI images were acquired to help aligning both the prostate gland and the phased array perpendicularly to each other. A baseline image was produced before driving the phased array. Another image was produced five minutes after driving the transducer. These images were used to calculate thermal distribution through the prostate gland. A smaller region of interest (ROI) area inside the prostate was used to average the temperature value and to feedback the controller system. Each controlled hyperthermia experiment was executed for 20 minutes.

## Results

###
*Ex vivo* results

*ex vivo*experiments using MRI thermometry were conducted for 20 minutes. Figure 6a shows a transverse MRI image of the coupled transrectal probe to an

*ex vivo*bovine tissue sample with dimensions of 100 × 70 × 4 mm. Water bolus provides good coupling medium between the active elements of the array and the tissue. Figure 6b shows the calculated relative thermal distribution after driving the transducer for five minutes. The color bar illustrates the relative temperatures in °C. Ultrasound energy is concentrated 20 mm away from the face of the transducer and is spread axially for 30 mm. Temperature increases vary from 5°C to 9°C within the focal region. The water bolus temperature is kept constant during heating period. Figure 6c shows the results of

*ex vivo*controlled hyperthermia using MRI thermometry. Aiming at 6°C relative rise, the averaged temperature of the region of interest is raised 5.9 ± 0.38°C in 9.5 ± 0.26 minutes and is kept till the end of the experiment. The solid continuous line represents averaged temperature values of seven different experiments. The standard error bars are shown at discrete points of 30 seconds intervals.

###
*In vivo* results

*in vivo*controlled hyperthermia. With a desired relative temperature of 6°C, results show that the temperature of the ROI is risen 6.1 ± 0.80°C in 6.3 minutes and is maintained approximately steady till the end of the experiment. The solid line represents discrete temperature values every 7 seconds.

## Discussion

The 4 × 20 element phased array provides focusing of the pressure wavefield within the prostate gland. The spreading of the focal volume in the length of the array (the elevation-direction or x-direction) is achieved by recruiting more segments to heat the whole prostate gland. Rayleigh-Sommerfeld and *k*-space simulations help in predicting the appropriate dimensions of the array. Good agreement between exposimetry results and the simulated *k*-space results was achieved. As an example, the -3 dB distance of the focal volume in the propagation direction (z-direction) is off by 9% between exposimetry and *k*-space simulations. Hyperthermia experiments of the focused probe were compared to a 16-element unfocused transducer [34]. With a desired relative temperature of 6°C, the controlled hyperthermia experiments show that the steady temperature of the ROI is maintained at 6.5 ± 0.93°C and 42.8 ± 1.44°C for *ex vivo* and *in vivo* experiments, respectively. Compared to unfocused transducers, however, the focused transducer has the ability of focusing acoustic energy in targeted tissue and at the same time has the ability to steer the beam for better treatment. Unfocused transducer spreads the energy in a fan-shaped profile in the tissue in front of the transducer. *In vivo* canine prostate hyperthermia trial proves the usefulness of the focused probe in prostate treatment. Blood flow can be considered a natural cooling system that works against temperature elevation within the prostate. The tested probes are capable of counteracting the effect of blood cooling while keeping the targeted volume within the required biological thermal dose.

Tissue-ultrasound interaction requires simulation of the ultrasound perturbations produced from phased arrays instead of summing the pressure contribution of geometrically superimposed simple sources. This requirement becomes feasible using the *k*-space computational method which provides economical and accurate simulation tool for large scale, coarse grid and inhomogeneous tissue models. Simulation results of the *k*-space are in good agreement with actual exposimetry results.

The 4 × 20 phased array intentionally spreads the focal volume in the length of the array (x-direction) and allows for varying in the width of the array (y-direction) while changing the depth of the focusing in the axial direction (z-direction). These variable parameters allow better thermal targeting of the whole prostate gland and the seminal vesicles. Controlling the temperature of a single point within the targeted volume helps in delivering the required clinical thermal dose into the targeted volume while maintaining surrounded desired tissue. Noninvasive MRI thermometry is essential in monitoring and controlling of thermal treatment of the prostate cancer. Ultimately, this research has benefited from two non-invasive technologies to help develop treatment for prostate cancer in conjunction with classical therapeutic modalities.

## Declarations

### Acknowledgements

This work was supported by the Department of Defense Congressionally Directed Medical Prostate Cancer Research Program (DAMD17-0201-0124).

## Authors’ Affiliations

## References

- Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ:
**Cancer statistics, 2004.***CA Cancer J Clin*2004,**54:**8–29.View ArticleGoogle Scholar - Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ:
**Cancer statistics, 2005.***CA Cancer J Clin*2005,**55:**10–30.View ArticleGoogle Scholar - Stanford JL, Stephenson RA, Cerhan J, Correa R, Eley JW, Gilliland F, Hankey B, Kolonel LN, Kosary C, Ross R, Severson R, West D:
*Prostate Cancer Trends 1973–1995. NIH Pub. 99–4543.*Bethesda, MD, SEER Program, National Cancer Institute; 1999.Google Scholar - Jones EL, Oleson JR, Prosnitz LR, Samulski TV, Vujaskovic Z, Yu D, Sanders LL, Dewhirst MW:
**Randomized trial of hyperthermia and radiation for superficial tumors.***J Clin Oncol*2005,**23:**3079–3085. 10.1200/JCO.2005.05.520View ArticleGoogle Scholar - Sherar M, Liu FF, Pintilie M, Levin W, Hunt J, Hill R, Hand J, Vernon C, van Rhoon G, van der Zee J, Gonzalez DG, van Dijk J, Whaley J, Machin D:
**Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial.***Int J Radiat Oncol Biol Phys*1997,**39:**371–380. 10.1016/S0360-3016(97)00333-7View ArticleGoogle Scholar - van der ZJ, Gonzalez GD, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA:
**Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperthermia Group.***Lancet*2000,**355:**1119–1125. 10.1016/S0140-6736(00)02059-6View ArticleGoogle Scholar - van der ZJ, Gonzalez GD:
**The Dutch Deep Hyperthermia Trial: results in cervical cancer.***Int J Hyperthermia*2002,**18:**1–12. 10.1080/02656730110091919View ArticleGoogle Scholar - Vernon CC, Hand JW, Field SB, Machin D, Whaley JB, van der Zee J, van Putten WL, van Rhoon GC, van Dijk JD, Gonzalez Gonzalez D, Liu FF, Goodman P, Sherar M:
**Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group.***Int J Radiat Oncol Biol Phys*1996,**35:**731–744. 10.1016/0360-3016(96)00154-XView ArticleGoogle Scholar - Seegenschmiedt M, Saur R:
*Interstitial and intracavitary thermoradiotherapy*. Berlin: Springer-Verlag; 1993.View ArticleGoogle Scholar - Seegenschmiedt M, Fressenden P, Vernon C:
*Principles and practices of thermoradiotherpy and thermochemotherapy*. Berlin: Springer-Verlag; 1995.View ArticleGoogle Scholar - Stauffer P, Diederich C, Seegenschmiedt M:
**Interstitial heating technologies.**In*Principles and practices of thermoradiotherapy and thermochemotherapy*. Edited by: Seegenschmiedt MH, Fessenden P, Vernon C. Berlin: Springer-Verlag; 1995:279–320.View ArticleGoogle Scholar - Sneed PK, Phillips TL:
**Combining hyperthermia and radiation: how beneficial?***Oncology (Williston Park)*1991,**5:**99–108.Google Scholar - Bornstein BA, Zouranjian PS, Hansen JL, Fraser SM, Gelwan LA, Teicher BA, Svensson GK:
**Local hyperthermia, radiation therapy, and chemotherapy in patients with local-regional recurrence of breast carcinoma.***Int J Radiat Oncol Biol Phys*1993,**25:**79–85.View ArticleGoogle Scholar - Overgaard J, Gonzalez GD, Hulshof MC, Arcangeli G, Dahl O, Mella O, Bentzen SM:
**Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology.***Int J Hyperthermia*1996,**12:**3–20.View ArticleGoogle Scholar - Van VM, De Leeuw AA, Raaymakers BW, Van Moorselaar RJ, Hofman P, Lagendijk JJ, Battermann JJ:
**Radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate cancer: preliminary results.***BJU Int*2004,**93:**36–41. 10.1111/j.1464-410X.2004.04551.xView ArticleGoogle Scholar - Diederich CJ, Hynynen K:
**Ultrasound technology for hyperthermia.***Ultrasound Med Biol*1999,**25:**871–887. 10.1016/S0301-5629(99)00048-4View ArticleGoogle Scholar - Saleh KY, Smith NB:
**Two-dimensional ultrasound phased array design for tissue ablation for treatment of benign prostatic hyperplasia.***Int J Hyperthermia*2004,**20:**7–31. 10.1080/0265673031000150867View ArticleGoogle Scholar - Saleh K, Smith N:
**Design and evaluation of a 3 × 21 element 1.75 dimensional tapered ultrasound phased array for the treatment of prostate disease.***Materials Research Innovations*2004.Google Scholar - Curiel L, Chavrier F, Souchon R, Birer A, Chapelon JY:
**1.5-D high intensity focused ultrasound array for non-invasive prostate cancer surgery.***IEEE Trans Ultrason Ferroelectr Freq Control*2002,**49:**231–242. 10.1109/58.985707View ArticleGoogle Scholar - Tan JS, Frizzell LA, Sanghvi N, Wu SJ, Seip R, Kouzmanoff JT:
**Ultrasound phased arrays for prostate treatment.***J Acoust Soc Am*2001,**109:**3055–3064. 10.1121/1.1373444View ArticleGoogle Scholar - Sokka SD, Hynynen KH:
**The feasibility of MRI-guided whole prostate ablation with a linear aperiodic intracavitary ultrasound phased array.***Phys Med Biol*2000,**45:**3373–3383. 10.1088/0031-9155/45/11/319View ArticleGoogle Scholar - Hutchinson EB, Buchanan MT, Hynynen K:
**Design and optimization of an aperiodic ultrasound phased array for intracavitary prostate thermal therapies.***Med Phys*1996,**23:**767–776. 10.1118/1.597741View ArticleGoogle Scholar - Hutchinson EB, Hynynen K:
**Intracavitary ultrasound phased arrays for prostate thermal therapies: MRI compatibility and in vivo testing.***Med Phys*1998,**25:**2392–2399. 10.1118/1.598450View ArticleGoogle Scholar - Diederich CJ, Hynynen K:
**The Feasibility of Using Electrically Focused Ultrasound Arrays to Induce Deep Hyperthermia Via Body Cavities.***Ieee Transactions on Ultrasonics Ferroelectrics and Frequency Control*1991,**38:**207–219. 10.1109/58.79605View ArticleGoogle Scholar - Buchanan MT, Hynynen K:
**Design and experimental evaluation of an intracavitary ultrasound phased array system for hyperthermia.***IEEE Trans Biomed Eng*1994,**41:**1178–1187. 10.1109/10.335866View ArticleGoogle Scholar - Zemanek J:
**Beam behavior within the nearfield of a vibrating piston.***J Acoust Soc Am*1971,**49:**181–191. 10.1121/1.1912316View ArticleGoogle Scholar - Mast TD, Souriau LP, Liu DL, Tabei M, Nachman AI, Waag RC:
**A k-space method for large-scale models of wave propagation in tissue.***IEEE Trans Ultrason Ferroelectr Freq Control*2001,**48:**341–354. 10.1109/58.911717View ArticleGoogle Scholar - Tabei M, Mast TD, Waag RC:
**A k-space method for coupled first-order acoustic propagation equations.***J Acoust Soc Am*2002,**111:**53–63. 10.1121/1.1421344View ArticleGoogle Scholar - Al-Bataineh O, Mast T, Park E, Sparrow V, Keoian R, Smith NB:
**Utilization of the k-space method in the design of a ferroelectric hyperthermia phased array.***Ferroelectrics*2006,**331:**103–120. 10.1080/00150190600736950View ArticleGoogle Scholar - Al-Bataineh O:
**A transrectal ultrasound phased array applicator for hyperthermia treatment of prostate cancer.***PhD thesis*. The Pennsylvania State University; 2005.Google Scholar - Mast TD, Faidi W, Makin IRS:
**Acoustic propagation effects in therapeutic ultrasound.***Therapeutic Ultrasound: 5th International Symposium on Therapeutic Ultrasound (American Institute of Physics Conference Proceedings)*2005,**829:**3–7.View ArticleGoogle Scholar - Witte DC, Richards RG:
**The pseudospectral method for simulating wave propagation.**In*Computational acoustics*. Edited by: Lee D, Cakmak A, Vichnevetsky R. New York: North-Holland; 1990:1–18.Google Scholar - Twizell EH:
*Computational methods for partial differential equations*. New York: Ellis Horwood Limited; 1984.Google Scholar - Smith NB, Buchanan MT, Hynynen K:
**Transrectal ultrasound applicator for prostate heating monitored using MRI thermometry.***Int J Radiat Oncol Biol Phys*1999,**43:**217–225. 10.1016/S0360-3016(98)00366-6View ArticleGoogle Scholar - Hazle JD, Diederich CJ, Kangasniemi M, Price RE, Olsson LE, Stafford RJ:
**MRI-guided thermal therapy of transplanted tumors in the canine prostate using a directional transurethral ultrasound applicator.***J Magn Reson Imaging*2002,**15:**409–417. 10.1002/jmri.10076View ArticleGoogle Scholar - Sun L, Collins CM, Schiano JL, Smith MB, Smith NB:
**Adaptive real-time closed-loop temperature control for ultrasound hyperthermia using magnetic resonance thermometry.***Concepts in Magnetic Resonance Part B-Magnetic Resonance Engineering*2005,**27B:**51–63. 10.1002/cmr.b.20046View ArticleGoogle Scholar - Sapareto SA, Dewey WC:
**Thermal dose determination in cancer therapy.***Int J Radiat Oncol Biol Phys*1984,**10:**787–800.View ArticleGoogle Scholar - Mast TD:
**Empirical relationships between acoustic parameters in human soft tissues.***Acoustics Research Letters Online*2000,**1:**37–42. 10.1121/1.1336896View ArticleGoogle Scholar - Mast TD:
**Two- and three-dimensional simulations of ultrasonic propagation through human breast tissue.***Acoustics Research Letters Online*2001,**3:**53–58. 10.1121/1.1447722View ArticleGoogle Scholar - Mast TD, Hinkelman LM, Metlay LA, Orr MJ, Waag RC:
**Simulation of ultrasonic pulse propagation, distortion, and attenuation in the human chest wall.***J Acoust Soc Am*1999,**106:**3665–3677. 10.1121/1.428209View ArticleGoogle Scholar - AIUM/NEMA:
**Safety standard for diagnostic for ultrasound equipment.***Journal of Ultrasound in Medicine*1983,**2:**S1-S50.Google Scholar - Chung AH, Hynynen K, Colucci V, Oshio K, Cline HE, Jolesz FA:
**Optimization of spoiled gradient-echo phase imaging for in vivo localization of a focused ultrasound beam.***Magn Reson Med*1996,**36:**745–752.View ArticleGoogle Scholar

## Copyright

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.